Jazz Pharma director plans 2,506-share stock sale

Jazz Pharmaceuticals plc (JAZZ) is the issuer of common stock that director Bruce C. Cozadd plans to sell under Rule 144.

Rhea-AI Filing Summary

Jazz Pharmaceuticals plc (JAZZ) is the issuer of common stock that director Bruce C. Cozadd plans to sell under Rule 144. The notice covers a proposed sale of 2,506 common shares through E*TRADE, with an indicated market value of $612,817.00 as of August 31, 2026. The securities to be sold arise from restricted stock vesting treated as compensation. Cozadd has also reported sales totaling 18,000 common shares over the prior three months, on June 1, July 1, and August 3, 2026, for stated dollar amounts.

Key Figures

Planned shares to be sold: 2,506 shares Indicated market value: $612,817.00 Past sale on August 3, 2026: 6,000 shares for $1,517,880.00 +2 more

5 metrics

Planned shares to be sold 2,506 shares Common stock covered by current Rule 144 notice

Indicated market value $612,817.00 Value associated with 2,506 shares as of August 31, 2026

Past sale on August 3, 2026 6,000 shares for $1,517,880.00 Common stock sold during the past 3 months

Past sale on July 1, 2026 6,000 shares for $1,442,820.00 Common stock sold during the past 3 months

Past sale on June 1, 2026 6,000 shares for $1,410,720.00 Common stock sold during the past 3 months

Key Terms

Rule 144, restricted stock vesting, Compensation, power of attorney

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"COMMON | 08/28/2026 | RESTRICTED STOCK VESTING | ISSUER"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Compensation financial

"2506 | 08/28/2026 | Compensation"

power of attorney regulatory

"Signature | /s/Paz Dizon by power of attorney for Bruce C. Cozadd"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Bruce C. Cozadd’s Form 144 filing mean for JAZZ stock?

The filing states that director Bruce C. Cozadd intends to sell up to 2,506 Jazz Pharmaceuticals plc common shares under Rule 144, with an indicated market value of $612,817.00 as of August 31, 2026. It is a notice of a potential resale, not an executed trade record.

How many JAZZ shares are covered by the new planned Rule 144 sale?

The notice covers a proposed sale of 2,506 shares of Jazz Pharmaceuticals plc common stock. These shares are associated with restricted stock vesting characterized as compensation and are to be sold through E*TRADE on NASDAQ, with an indicated value of $612,817.00.

What prior JAZZ share sales has Bruce C. Cozadd reported in this Form 144?

The filing lists three prior sales in the past three months: 6,000 shares on June 1, 2026 for $1,410,720.00; 6,000 shares on July 1, 2026 for $1,442,820.00; and 6,000 shares on August 3, 2026 for $1,517,880.00.

What is the nature of the JAZZ securities to be sold by Bruce C. Cozadd?

The securities are JAZZ common stock arising from restricted stock vesting categorized as compensation. The vesting date shown is August 28, 2026, with 2,506 shares indicated in the "Securities To Be Sold" section.

On which market is the planned JAZZ share sale by Bruce C. Cozadd indicated?

The proposed sale of 2,506 Jazz Pharmaceuticals plc common shares is indicated for trading on NASDAQ, with E*TRADE listed as the broker and an indicated market value of $612,817.00 as of August 31, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/31/2026 - 03:11 PM EDT Accepted by SEC EDGAR 08/31/2026 - 03:10 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001193210
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Jazz Pharmaceuticals plc
SEC File Number	001-33500
Address of Issuer	FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN IRELAND D04 E5W7
Phone	353-1-634-7800
Name of Person for Whose Account the Securities are To Be Sold	COZADD BRUCE C
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	ETRADE FINANCIAL CORPORATION 3 EDISON DRIVE ALPHARETTA GA 30005	2506	612817.00	64914577	08/31/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	08/28/2026	RESTRICTED STOCK VESTING	ISSUER			2506	08/28/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
COZADD BRUCE C. 3000 El Camino Real 2 Palo Alto Square, Suite 600 Palo Alto CA 94306	COMMON	08/03/2026	6000	1517880.00
COZADD BRUCE C. 3000 El Camino Real 2 Palo Alto Square, Suite 600 Palo Alto CA 94306	COMMON	07/01/2026	6000	1442820.00
COZADD BRUCE C. 3000 El Camino Real 2 Palo Alto Square, Suite 600 Palo Alto CA 94306	COMMON	06/01/2026	6000	1410720.00

144: Remarks and Signature

Remarks
Date of Notice	08/31/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Paz Dizon by power of attorney for Bruce C. Cozadd
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)